197 related articles for article (PubMed ID: 26273262)
1. Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile.
Neufeld PM; Melhem Mde S; Szeszs MW; Ribeiro MD; Amorim Ede L; da Silva M; Lazéra Mdos S
Braz J Microbiol; 2015 Jun; 46(2):477-84. PubMed ID: 26273262
[TBL] [Abstract][Full Text] [Related]
2. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
3. In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines.
Testore GP; Dori L; Buonomini AR; Schito GC; Soro O; Fortina G; Andreoni S; Carlone N; Tullio V; Andreoni M
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):187-92. PubMed ID: 15541604
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole susceptibility of Brazilian Candida isolates assessed by a disk diffusion method.
Colombo AL; Da Matta D; De Almeida LP; Rosas R
Braz J Infect Dis; 2002 Jun; 6(3):118-23. PubMed ID: 12144747
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.
Azevedo AC; Bizerra FC; da Matta DA; de Almeida LP; Rosas R; Colombo AL
Mycopathologia; 2011 Jun; 171(6):411-6. PubMed ID: 21181497
[TBL] [Abstract][Full Text] [Related]
6. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Ellis D; Tullio V; Rodloff A; Fu W; Ling TA;
J Clin Microbiol; 2010 Apr; 48(4):1366-77. PubMed ID: 20164282
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
8. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
[TBL] [Abstract][Full Text] [Related]
9. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
10. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
11. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.
Aquino VR; Lunardi LW; Goldani LZ; Barth AL
Braz J Infect Dis; 2005 Oct; 9(5):411-8. PubMed ID: 16410893
[TBL] [Abstract][Full Text] [Related]
13. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.
Ziccardi M; Souza LO; Gandra RM; Galdino AC; Baptista AR; Nunes AP; Ribeiro MA; Branquinha MH; Santos AL
Int J Med Microbiol; 2015 Dec; 305(8):848-59. PubMed ID: 26319940
[TBL] [Abstract][Full Text] [Related]
14. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
Pfaller MA; Jones RN; Doern GV; Sader HS; Hollis RJ; Messer SA
J Clin Microbiol; 1998 Jul; 36(7):1886-9. PubMed ID: 9650930
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria.
Enwuru CA; Ogunledun A; Idika N; Enwuru NV; Ogbonna F; Aniedobe M; Adeiga A
Afr Health Sci; 2008 Sep; 8(3):142-8. PubMed ID: 19357740
[TBL] [Abstract][Full Text] [Related]
16. Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
Wang JL; Chang SC; Hsueh PR; Chen YC
J Microbiol Immunol Infect; 2004 Aug; 37(4):236-41. PubMed ID: 15340652
[TBL] [Abstract][Full Text] [Related]
17. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
Colombo AL; Nakagawa Z; Valdetaro F; Branchini ML; Kussano EJ; Nucci M
Med Mycol; 2003 Jun; 41(3):235-9. PubMed ID: 12964715
[TBL] [Abstract][Full Text] [Related]
19. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ
Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion.
Hazen KC; Baron EJ; Colombo AL; Girmenia C; Sanchez-Sousa A; del Palacio A; de Bedout C; Gibbs DL;
J Clin Microbiol; 2003 Dec; 41(12):5623-32. PubMed ID: 14662952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
